KAYA TİLKİ, E. And Ozturk, S. E. 2021. Targeting epigenetic chromatin modification enzymes upregulated by M2c macrophage polarization with a proteasome inhibitor ixazomib in lung cancer: a novel approach. EUROPEAN JOURNAL OF IMMUNOLOGY , vol.51 , 308.

KAYA TİLKİ, E., & Ozturk, S. E., (2021). Targeting epigenetic chromatin modification enzymes upregulated by M2c macrophage polarization with a proteasome inhibitor ixazomib in lung cancer: a novel approach. EUROPEAN JOURNAL OF IMMUNOLOGY , vol.51, 308.

KAYA TİLKİ, ELİF, And Selin Engur Ozturk. "Targeting epigenetic chromatin modification enzymes upregulated by M2c macrophage polarization with a proteasome inhibitor ixazomib in lung cancer: a novel approach," EUROPEAN JOURNAL OF IMMUNOLOGY , vol.51, 308, 2021

KAYA TİLKİ, ELİF K. And Ozturk, Selin E. . "Targeting epigenetic chromatin modification enzymes upregulated by M2c macrophage polarization with a proteasome inhibitor ixazomib in lung cancer: a novel approach." EUROPEAN JOURNAL OF IMMUNOLOGY , vol.51, pp.308, 2021

KAYA TİLKİ, E. And Ozturk, S. E. (2021) . "Targeting epigenetic chromatin modification enzymes upregulated by M2c macrophage polarization with a proteasome inhibitor ixazomib in lung cancer: a novel approach." EUROPEAN JOURNAL OF IMMUNOLOGY , vol.51, p.308.

@article{article, author={ELİF KAYA TİLKİ And author={Selin Engur Ozturk}, title={Targeting epigenetic chromatin modification enzymes upregulated by M2c macrophage polarization with a proteasome inhibitor ixazomib in lung cancer: a novel approach}, journal={EUROPEAN JOURNAL OF IMMUNOLOGY}, year=2021, pages={308} }